about
Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathwayAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisAlternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.Early gestation chorionic villi-derived stromal cells for fetal tissue engineeringIn vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragmentTrichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models.Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by ChemotherapyThe Role of Putative Phosphatidylserine-Interactive Residues of Tissue Factor on Its Coagulant Activity at the Cell Surface.sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.Tissue factor as a novel target for treatment of breast cancerThe prothrombotic activity of cancer cells in the circulationTissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signalingThe prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy.Inhibitors of the initiation of coagulation.The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.MicroRNA-20b and ERK1/2 pathway independently regulate the expression of tissue factor in hematopoietic and trophoblastic differentiation of human embryonic stem cells.Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.Tissue factor as a novel marker for detection of circulating cancer cells.Emodin inhibits HMGB1-induced tumor angiogenesis in human osteosarcoma by regulating SIRT1.Blood coagulation and blood vessel development: is tissue factor the missing link?Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.Microfluidic isolation of platelet-covered circulating tumor cells.The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients.Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1.Synthesis and characterization of (18)F-labeled active site inhibited factor VII (ASIS).The role of tissue factor and protease-activated receptor 2 in endometriosis.
P2860
Q28385231-8E8F8128-9284-42D9-8790-0E8F38D2C6C4Q28397726-BEC74279-FB5B-48E3-9AB5-E8338CD2E2F7Q34308216-2FB04A84-DC5C-410A-B2B0-F4FB52FD0845Q34557179-A9944314-1463-44B0-A454-165BDBF50BD0Q34992001-31670AB0-8CBE-45FE-BAE1-302ACB0466B3Q35174206-5A61EB4C-12E7-45EE-8300-0DCC9CFD2F30Q35788352-6884D0EB-5A4C-4368-985B-B41F5C95ED3BQ35813871-B2859B1E-0532-4761-BB7E-F51F8B8497D8Q35813885-F995E42C-36FF-47F5-8705-ED7EB37AE51DQ35990029-9F692923-2D3D-494A-9142-3843E12387D0Q36009299-5183153E-586D-41CF-8A25-F5133992C776Q36062304-42B90E20-3F40-40CD-AC61-3CE77BF07F85Q36544702-5B2C75F2-B863-455D-8E28-E58B34A67A56Q36565603-C950B87D-7934-4DDF-99D1-16FDE5DD3D1EQ37088087-CB930683-669B-487A-9AED-A82927F6B263Q37151056-C42E9CD7-4CF3-4408-BCFD-B02B76E1C5A2Q37193598-BFA9E551-E460-4C31-B404-8DDA3849D2B5Q37662270-A64CE69C-1B0B-4F4F-90DA-D0E24A5C459EQ37851554-FB0AB63A-5278-43C6-992C-14B1386CAC69Q38747529-5D4AF865-123A-449C-B759-E1AF6FC327FBQ38750674-97461B95-304A-4B10-B947-0C71E31549C1Q39036023-52892E13-726B-4F37-889F-78E44FEDEB17Q39173889-0E1BC0B8-4FF4-4FD2-A136-82D3C00BE229Q39413655-2B0B0F97-E252-43CA-8947-173FA1F1C4F7Q39624307-2857447F-7679-42DB-9D16-F6CC0E243B2FQ41995659-21655437-80AD-41F3-A901-88A59C97BDA0Q42320934-8E597947-1AA2-4253-95D8-F41F1F722EF3Q42374080-FBB225EF-83F2-4D54-987E-D56473017615Q45863643-4D688A48-88D4-4756-A274-8622FA7F677EQ47653261-BBC70D1B-90C7-4E35-8720-CA41DE23E4E4Q51036455-20EF8E5E-31CC-4155-8370-DFA6D3E1237CQ51730485-6CA15934-86EE-42DB-A742-12DC83F1CA68Q52316878-3D3BA871-729D-4BE1-9F2F-24C771E622C1Q53562827-A89FC5CF-AF6D-4B87-AB85-53A622DCDB77Q54306514-56E7056D-FCD1-4EEC-8214-AFED17BE5525
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tissue factor in cancer progression and angiogenesis.
@en
Tissue factor in cancer progression and angiogenesis.
@nl
type
label
Tissue factor in cancer progression and angiogenesis.
@en
Tissue factor in cancer progression and angiogenesis.
@nl
prefLabel
Tissue factor in cancer progression and angiogenesis.
@en
Tissue factor in cancer progression and angiogenesis.
@nl
P2093
P2860
P1433
P1476
Tissue factor in cancer progression and angiogenesis.
@en
P2093
Florence Schaffner
Naho Yokota
Wolfram Ruf
P2860
P356
10.1016/S0049-3848(10)70010-4
P478
125 Suppl 2
P577
2010-04-01T00:00:00Z